XILINX INC
10-Q, 1996-11-12
SEMICONDUCTORS & RELATED DEVICES
Previous: HOMESTAKE MINING CO /DE/, 10-Q, 1996-11-12
Next: JMB INCOME PROPERTIES LTD XI, 10-Q, 1996-11-12



                                      
                                UNITED STATES
                      SECURITIES AND EXCHANGE COMMISSION

                           WASHINGTON, D.C.  20549

                                  FORM 10-Q


(Mark  One)
[  X  ]    Quarterly  report pursuant to Section 13 or 15(d) of the Securities
Exchange  Act  of 1934 for the quarterly period ended   September 28, 1996    
or
[     ]  Transition report pursuant to section 13 or 15(d) of the Securities
Exchange  Act  of  1934  for  the  transition  period  from  ____  to ____  .


               Commission File Number                   0-18548


                                 Xilinx, Inc.
            (Exact name of registrant as specified in its charter)


              Delaware                                      77-0188631
  (State or other jurisdiction of             (I.R.S. Employer Identification
   incorporation or organization)                                  Number)


  2100 Logic Drive, San Jose, California                             95124
(Address of principal executive offices)                          (Zip Code)


                                (408) 559-7778
             (Registrant's telephone number, including area code)




Indicate  by  check  mark  whether  the  registrant  (1) has filed all reports
required  to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934  during  the  preceding  12  months  (or for such shorter period that the
registrant  was  required  to  file such reports), and (2) has been subject to
such  requirements  for  the  past  90  days.
                                          YES   [ X ]            NO     [   ]


Class                            Shares  Outstanding  at  September  28,  1996

Common Stock, $.01 par value                              72,957,000








                                 XILINX, INC.
                  CONSOLIDATED CONDENSED STATEMENT OF INCOME
                   (in thousands except per share amounts)



<TABLE>
<CAPTION>

                                   Three Months Ended      Six Months Ended
                                  Sept. 28,  Sept. 30,  Sept. 28,   Sept. 30,
                                      1996       1995       1996       1995
                                  --------- ---------   ----------  ----------
<S>                              <C>         <C>        <C>          <C>
Net revenues                     $ 130,579   $ 141,212   $ 280,779   $ 266,972
Costs and expenses:
   Cost of revenues                 50,658      51,614     103,983     100,120 
   Write-off of discontinued 
     product family                  5,000           -       5,000           - 
   Research and development         16,748      16,652      34,585      31,505 
   Marketing, general and 
     administrative                 28,709      27,271      58,257      52,237 
   Non-recurring charges                 -           -           -      19,366 
                                 ----------  ----------  ----------  ---------

    Operating costs and expenses   101,115      95,537     201,825     203,228 
                                 ----------  ----------  ----------  ---------
Operating income                    29,464      45,675      78,954      63,744 

Interest and other income            5,407       1,400       9,767       3,258 
Interest expense                    (3,437)       (105)     (6,912)      (163)
                                 ----------  ----------  ----------  ---------

Income before provision for taxes
     on income                      31,434      46,970      81,809      66,839 

Provision for taxes on income       10,216      17,144      28,099      31,465 
                                 ----------  ----------  ----------  ---------

Net income                       $  21,218   $  29,826   $  53,710   $  35,374 
                                 ==========  ==========  ==========  =========

Net income per share             $    0.27   $    0.37   $    0.68   $   0.45 
                                 ==========  ==========  ==========  =========

Common and common equivalent
    shares used in computing
    per share amounts               79,378      79,601      79,161      78,545 
                                 ==========  ==========  ==========  =========
<FN>


     (See accompanying Notes to Consolidated Condensed Financial Statements.)

</TABLE>
<PAGE>
 
<TABLE>
<CAPTION>
                                         XILINX, INC.
                              CONSOLIDATED CONDENSED BALANCE SHEET
                            (in thousands except per share amounts)

                                                     Sept. 28,    March 30,
                                                       1996         1996
                                                    -----------   ---------    
<S>                                                 <C>          <C>
ASSETS
Current assets:
    Cash and cash equivalents                       $  114,081   $  110,893 
    Short-term investments                             309,403      267,068 
    Accounts receivable, net                            67,375       79,528 
    Inventories                                         63,407       39,238 
    Deferred income taxes and other current assets      36,949       41,979 
                                                    -----------  -----------

Total current assets                                   591,215      538,706 

Property, plant and equipment, at cost                 145,418      128,283 
Accumulated depreciation and amortization              (55,894)     (45,645)
                                                    -----------  -----------
    Net property, plant and equipment                   89,524       82,638 

Restricted investments                                  36,228       36,212 
Investment in joint venture                             35,200       34,316 
Advances for wafer purchases                            30,000            - 
Developed technology and other assets                   27,546       29,008 
                                                    -----------  -----------

                                                    $  809,713   $  720,880 
                                                    ===========  ===========

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
    Accounts payable, accrued liabilities
        and income taxes payable                    $   80,850   $   64,082 
    Deferred income on shipments to distributors        39,188       37,568 
    Current obligations under capital leases               508          986 
                                                    -----------  -----------

Total current liabilities                              120,546      102,636 

Long-term debt                                         250,000      250,000 

Stockholders' equity:
    Preferred stock, $.01 par value                          -            - 
    Common stock, $.01  par value                          730          719 
    Additional paid-in capital                         117,222      100,020 
    Retained earnings                                  321,215      267,505 
                                                    -----------  -----------

                Total stockholders' equity             439,167      368,244 
                                                    -----------  -----------

                                                    $  809,713   $  720,880 
                                                    ===========  ===========
<FN>

(See accompanying Notes to Consolidated Condensed Financial Statements.)

</TABLE>


<PAGE>

<TABLE>
<CAPTION>
 

                                XILINX, INC.
                CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS
               Increase (decrease) in cash and cash equivalents
                                (in thousands)


                                                           Six Months Ended
                                                         Sept. 28,   Sept. 30,
                                                           1996        1995
                                                      -----------  ----------   
<S>                                                    <C>          <C>
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income                                              $   53,710  $  35,374
Adjustments to reconcile net income to net cash
      provided by operating activities:
           Write-off of in-process technology                    -     19,366 
           Depreciation and amortization                    12,770      9,285 
           Undistributed earnings of joint venture            (408)         - 
           Changes in assets and liabilities net
              of effects of NeoCAD acquisition:
                   Accounts receivable                      12,153    (24,190)
                   Inventories, including the impact of    (15,206)    15,077 
                       receipts against advances
                       for wafer purchases
                   Deferred income taxes and other          (1,041)    (2,826)
                   Accounts payable, accrued
                        liabilities and income              16,768      3,549 
                        taxes payable
                   Deferred income on shipments to           1,620      9,044 
                        distributors                                      
                                                         ---------- ----------
                           Total adjustments net of         26,656     29,305 
                              effects of NeoCAD 
                              acquisition                           
                                                         ---------- ----------
                   NET CASH PROVIDED BY OPERATING           80,366     64,679 
                      ACTIVITIES

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of short-term available-for-sale                (178,216)   (39,631)
    investments
Proceeds from sale or maturity of short-term               135,134     61,917 
    available-for-sale investments
Purchases of restricted held-to-maturity                   (36,109)   (52,599)
    investments
Proceeds from maturity of restricted held-to-               36,092     28,840 
    maturity investments
Advances for wafer purchases                               (30,000)         - 
Acquisition of NeoCAD, net of cash acquired                      -    (33,412)
Property, plant and equipment                              (17,151)   (25,081)
                                                         ---------- ----------
                   NET CASH USED IN INVESTING              (90,250)   (59,966)
                     ACTIVITIES

CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on capital lease obligations               (478)      (847)
Proceeds from issuance of common stock                      13,550      6,868 
                                                        ----------- ----------
                    NET CASH PROVIDED BY FINANCING          13,072      6,021 
                      ACTIVITIES 

Net increase in cash and cash equivalents                    3,188     10,734 
Cash and cash equivalents at beginning of period           110,893     56,703 
                                                        ----------- ----------
Cash and cash equivalents at end of period              $  114,081  $  67,437 
                                                        =========== ==========

Schedule of non-cash transactions:
    Tax benefit from stock options                      $    4,345  $   4,197 
    Issuance of treasury stock under employee                    -      4,417 
       stock plans    
    Receipts against advances for wafer purchases            8,963     13,709 
Supplemental disclosures of cash flow information:
    Interest paid                                       $    6,068  $     163
    Income taxes paid                                       22,773     29,274

<FN>
(See accompanying Notes to Consolidated Condensed Financial Statements.)

</TABLE>


XILINX, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS




1.        The accompanying interim consolidated financial statements have been
pre-pared  in  conformity  with  generally  accepted accounting principles and
should  be  read  in  conjunction with the Xilinx, Inc. consolidated financial
statements  for the year ended March 30, 1996.  The balance sheet at March 30,
1996  is  derived  from  audited  financial statements.  The interim financial
statements  are unaudited but reflect all adjustments which are in the opinion
of  management  of  a  normal,  recurring  nature  necessary to present a fair
statement  of  results for the interim periods presented.  The results for the
six  month  period  ended September 28, 1996 are not necessarily indicative of
the  results  that  may  be  expected  for  the  year  ending  March 29, 1997.

2.        Inventories are stated at the lower of cost (first-in, first-out) or
market  (estimated  net  realizable value).  Inventories at September 28, 1996
and  March  30,  1996  are  as  follows:



<TABLE>
<CAPTION>
                                September 28,   March 30,
                                     1996          1996
                                --------------  ----------     

<S>                             <C>             <C>
               Raw materials    $        5,241  $    5,886
               Work-in-process          41,447      21,927
               Finished goods           16,719      11,425
                                --------------  ----------
                                $       63,407  $   39,238
                                ==============  ==========
</TABLE>



3.          On  May 17, 1996, the Company signed an agreement with Seiko Epson
Corporation  (Seiko),  a  primary  wafer supplier.  The agreement provides for
total  payments  to  Seiko of $300 million to be used in the construction of a
wafer  fabrication  facility in Japan which will provide access to eight-inch,
sub-micron  wafers.  Of the total payments, $200 million represents an advance
payment  for  future wafer deliveries.  In conjunction with the agreement, $30
million  installments  were  paid  in  May  1996  and  on November 1, 1996 and
additional installments of $30 million are scheduled for May 1, 1997, November
1,  1997  and February 1, 1998 or upon the start of mass production, whichever
is later.  The final installment for the advance payment of $50 million is due
on  or after the later of April 1, 1998 or the date the outstanding balance of
the  advance  payment  is  less  than  $125 million.  As a result, the maximum
outstanding  amount  of the advance payment at any time will be $175 million. 
Repayment  of  this advance will be in the form of wafer deliveries using U.S.
dollar  denominated  pricing.    Specific wafer pricing will be based upon the
prices  of  similar  wafers  manufactured  by  other, specifically identified,
leading-edge foundry suppliers.  Wafer deliveries are expected to begin in the
first  half of calendar 1998.  The advance payment provision also provides for
interest to be paid to the Company in the form of free wafers.  In addition to
the advance payments, the Company will provide further funding to Seiko in the
amount  of $100 million.  This additional funding will be paid after the final
installment  of  the  $200  million  advance,  and  the form of the additional
funding  will  be  negotiated  at  that  time.

4.          During  the  three  months  ended  September 28, 1996, the Company
discontinued  the XC8100 family of one-time programmable antifuse devices.  As
a result, the Company recorded a pretax charge against earnings of $5 million.
 This  charge primarily relates to the write-off of inventories held by Xilinx
and  its  distributors  and  for  termination  charges  relating  to  purchase
commitments  to  foundry  partners  for  wafers  which  have not completed the
manufacturing  process.

<PAGE>
5.        On September 16, 1996, the Company's Board of Directors authorized a
stock  repurchase  program  whereby  up  to  2 million shares of the Company's
common  stock  may be purchased in the open market from time to time as market
and  business conditions warrant.  The Company plans to use shares repurchased
to  meet  the  stock  requirements  of the Company's Stock Option and Employee
Qualified  Stock  Purchase plans.  Through September 28, 1996, the Company had
not  repurchased  any  shares.    Through  November  8,  1996, the Company has
repurchased  490,000  shares  for  $15.7  million.

6.          The Company is currently involved in patent litigation with Altera
Corporation  (see  Part  II, Item 1, Legal Proceedings).  Due to the uncertain
nature of the litigation with Altera and because the lawsuits are still in the
pre-trial stage, the ultimate outcome of these matters cannot be determined at
this  time.    Management  believes  that  it has meritorious defenses to such
claims  and is defending them vigorously, and has not recorded a provision for
the  ultimate  outcome  of  these  matters  in  its financial statements.  The
foregoing  is a forward looking statement based on information presently known
to  management,  and  the  future  outcome  could  differ.




                                 XILINX, INC.
         MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
                           AND RESULTS OF OPERATIONS


The  statements  in this Management's Discussion and Analysis that are forward
looking  involve  numerous  risks  and  uncertainties and are based on current
expectations.    Actual  results  may  differ  materially.    Such  risks  and
uncertainties  are  detailed  below.


RESULTS  OF  OPERATIONS  -  SECOND QUARTER AND FIRST SIX MONTHS OF FISCAL 1997
COMPARED  TO  THE  SECOND  QUARTER  AND  FIRST  SIX  MONTHS  OF  FISCAL  1996

Revenue

Revenues for the second quarter of fiscal 1997 of $130.6 million represented a
$10.6 million, or 7.5%, decrease from the corresponding period of fiscal 1996.
 Revenues for the first six months of fiscal 1997 were $280.8 million, up 5.2%
from  the  corresponding  period  of 1996.  Revenues for the second quarter of
fiscal  1997  were  adversely  impacted  by  the  general  slowdown  in  the
semiconductor  industry,  seasonal  slowdown  in  Europe,  customer efforts to
reduce inventory levels, customer programs which have not ramped up as quickly
as  expected  and  price  reductions.   The revenue decrease during the second
quarter  of  fiscal 1997 was primarily attributable to decreases in the volume
of  shipments  relating  to  the  Company's XC2000 family, the non-proprietary
members  of  the  XC3000  family,  the  XC3100  family  and  the XC4000 family
partially  offset  by  increases  in  the  volume of shipments relating to the
XC5200  family.    Relative to the prior year quarter, revenues for the XC2000
family  decreased  $1.7  million,  or  41.7%, revenues for the non-proprietary
members of the XC3000 family decreased by $9.4 million, or 39.2%, revenues for
the  XC3100  family  decreased  by  $1.6 million, or 9.9% and revenues for the
XC4000  family  decreased $3.7 million, or 6%.  Revenues for the XC5200 family
increased  $6.7 million from $1.1 million in the prior year.  Revenues for the
Company's  first  generation  FPGA products, which includes the XC2000, XC3000
and  XC3100 families, represented 36.8% of aggregate component revenues in the
second  quarter  of fiscal 1997 and decreased 20.4% relative to the results of
the  comparable  quarter of the prior fiscal year.  Revenues for the Company's
second generation FPGA products, which includes the XC4000 and XC5200 families
as  well  as  the  recently  introduced  XC6200  family,  represented 51.5% of
aggregate  component  revenues  and  exceeded  the  revenues of the comparable
quarter  of  the  prior  
<PAGE>
year  by  5.1%.  The increase in revenues relating to the second generation of
products  is  primarily a function of increasing demand for the functionality,
performance  and  pricing  provided  by  these  product  families.   The other
products  generation,  consisting primarily of the CPLD families, the Hardwire
product and serial proms, represented 11.7% of aggregate component revenues in
the  second quarter of fiscal 1997 and decreased 11.1% relative to the results
of the comparable quarter of the prior year.  Proprietary products constituted
88.9% of revenues for the second quarter of fiscal 1997, as compared to 83% in
the comparable quarter last year.  Software revenues represented approximately
3%  of  total  revenues  for  all  periods  presented.

In the first half of 1996, several independent semiconductor industry analysts
have  indicated  a  belief  that  the  overall  semiconductor  industry  will
experience lower growth rates than those experienced over the last few years. 
See  "Factors  Affecting  Future Operating Results" for discussion relating to
potential  impact  of  semiconductor  industry  conditions  on  the  Company's
business.

The  Company  expects  its  growth rate in revenue for fiscal 1997 to decrease
from  the  levels  experienced  in fiscal 1996.  The Company believes that the
conditions that led to slow growth in the last two quarters of fiscal 1996 and
the  first  quarter  of  fiscal  1997  and a 13.1% decrease in revenue for the
second  quarter  of  fiscal  1997,  in comparison to the immediately preceding
quarter,  are  still  present.    The  Company  also realizes that a prolonged
slowdown  in  the  overall  semiconductor  industry would detrimentally impact
Xilinx.    Based  on current inventory levels and wafer capacity availability,
the  Company  is generally able to deliver products to customers within fairly
short  lead  times.    As  a result, the Company has recently experienced many
customers  placing  orders  for near-term delivery but not indicating a demand
for products in the intermediate to long-term range.  In this environment, the
level  of  customer orders for a given quarter is difficult to predict.  While
the  Company currently projects revenue growth rates for the last two quarters
of  fiscal 1997 to be in the low single-digit range, no assurance can be given
that  this  will  be  the  case.

The  preceding two paragraphs contain forward-looking statements which involve
risks and uncertainties.  The Company's actual results could differ materially
from  those  anticipated  in  these  forward-looking statements as a result of
certain  factors  including  those  set  forth  in  "Factors  Affecting Future
Operating  Results"  and  elsewhere  in  this  section.

Gross  Margin

Cost  of  revenues,  excluding  the  impact  of  the  $5 million non-recurring
write-off  relating  to the XC8100 product family, was $50.7 million, or 38.8%
of  revenues, and $104 million, or 37% of revenues, for the second quarter and
first  six  months  of  fiscal  1997, respectively.  Costs of revenues for the
comparable  periods  of  fiscal 1996 were $51.6 million, or 36.6% of revenues,
and  $100.1  million, or 37.5% of revenues, respectively.  The increase in the
cost  of  revenues  as  a  percentage of revenues during the second quarter of
fiscal  1997  over  the  comparable  quarter  of  the prior year was primarily
attributable  to product mix, price reductions, unfavorable overhead variances
resulting  from  lower  manufacturing volumes and increased inventory reserves
relating  to  an expanded level of inventory offset by the favorable impact of
lower  wafer  costs  (reflecting  the  strengthened  U.S. dollar exchange rate
against  the  yen)  and  improved  yields.   The Company was able to partially
offset  the negative impact of ongoing price erosion for its existing products
with  increased  volumes  of  newer, proprietary, higher margin products.  The
Company  recognizes  that ongoing price reductions for its integrated circuits
are  a  significant element in expanding the market for its products.  Company
management  believes  that the recent gross margins of up to 65.7% of revenues
are  neither  sustainable  nor desirable in the future.  Rather, gross margins
closer  to the historical range of 60% to 62% of revenues, including the 61.2%
gross  margin realized in the current quarter, are considered more appropriate
for  expanding market share while realizing acceptable returns, although there
can  be  no  assurance  that  future  gross  margins  will  be  in this range.

Research  and  Development

Research  and  development  expenditures  were  $16.7  million  for the second
quarter  and  $34.6  million  for  the  first  six  
<PAGE>
months  of  fiscal 1997, or 12.8% and 12.3% of revenues respectively, compared
to  $16.7 million and $31.5 million, or 11.8% of revenues for both periods, in
the comparable fiscal 1996 periods.  Research and development expenditures for
the second quarter of fiscal 1997 increased as a percentage of revenues as the
decline  in  revenues  outpaced  the  amount  of spending.  While research and
development  headcount increased in the second quarter of fiscal 1997 over the
comparable  fiscal  1996  period, the Company reduced purchases of engineering
wafers  and  supplies  in  the  current  period.    The  9.8% increase in such
expenditures  for  the  first  six  months  of  fiscal 1997 as compared to the
comparable  fiscal  1996  period  resulted  primarily from increased staffing,
higher  wafer  purchases,  and increased facility and support costs associated
with  an  expanded  scope  of  operations.  The Company remains committed to a
significant  level  of research and development effort in order to continue to
compete  aggressively  in  the  programmable  logic  marketplace.

Non-recurring  Charges

During  the  first  six-months  of  fiscal  1996, the Company incurred a $19.4
million  non-recurring  write-off  of  in-process  technology  relating to the
acquisition  of  NeoCAD,  Inc.

Marketing,  General  and  Administrative

Marketing,  general  and  administrative  expenses  were $28.7 million for the
second  quarter  and $58.3 million for the first six months of fiscal 1997, or
22%  and  20.7% of revenues, respectively, compared to $27.3 million and $52.2
million,  or  19.3%  and  19.6%  of  revenues, respectively, in the comparable
fiscal  1996  periods.  These expenses have increased in amount primarily as a
result  of increased staffing as well as increased marketing and sales related
costs.  Such expenses have increased as a percentage of revenues in the second
quarter  of  fiscal  1997  as  compared  to the comparable fiscal 1996 period,
reflecting  the  recent  decline in revenues.  The timing and extent of future
legal  costs  associated  with  the  ongoing  enforcement  of  the  Company's
intellectual  property rights are not readily predictable and may increase the
level  of  future  general  and  administrative  expenses.

Operating  Income

Operating  income,  excluding  the  impact  of  the  $5  million non-recurring
write-off  relating  to the XC8100 product family, was $34.5 million, or 26.4%
of  revenues, and $84 million, or 29.9% of revenues, for the second quarter of
fiscal  1997 and the first six months of fiscal 1997, respectively.  Operating
income  was  $45.7 million, or 32.3% of revenues, and $83.1 million (excluding
the  impact of the $19.4 million write-off of in-process technology associated
with  the  acquisition of NeoCAD), or 31.1% of revenues, respectively, for the
comparable  fiscal  1996  periods.    Excluding  the  impact  of non-recurring
write-offs, operating income decreased $11.2 million during the second quarter
of  fiscal  1997  as  compared  to the comparable period of the prior year but
increased  $.8  million during the first six months of fiscal 1997 as compared
to  the  comparable  period  of  the  prior  year.

Interest  and  other  income,  net

The  Company incurs interest expense on the $250 million of 5 1/4% convertible
notes issued in November 1995.  The Company earns interest income on its cash,
cash  equivalents,  short-term  investments, restricted investments and on the
outstanding  amount  of  the  advances  for  wafer  purchases.   The amount of
interest  earned  is a function of the balance of cash invested as well as the
prevailing  interest  rates.    The Company also records 25% of United Silicon
Inc.'s  net  income  as  joint  venture equity income.  Net interest and other
income  was  $2.0  million in the second quarter of fiscal 1997 as compared to
$1.3  million  during  the  comparable  prior  year  period.   The increase is
primarily  attributable  to  increased  interest  income resulting from higher
investment  portfolio balances and joint venture equity income.  The Company's
investment  portfolio contains tax-advantaged municipal bonds, which generally
have  pretax  yields  which are less than the interest rate on the convertible
notes.    For financial reporting purposes, the Company records the difference
between  the  pretax and tax-equivalent yields as a reduction in provision for
taxes  on  income.  As a result of the difference in yields and future uses of
the  investment portfolio, levels of net interest income could decrease in the
future.


<PAGE>
Provision  for  Income  Taxes

The  Company recorded a tax provision of $10.2 million (32.5% of income before
taxes)  for  the  second  quarter  of fiscal 1997 and a tax provision of $28.1
million (34.3% of income before taxes) for the first six months of fiscal 1997
as  compared to a tax provision for the second quarter of fiscal 1996 of $17.1
million (36.5% of income before taxes) and a provision for taxes for the first
six  months  of  fiscal 1996 of $31.5 million (47.1% of income before taxes). 
The  higher tax rate for the first six months of fiscal 1996 resulted from the
non-recurring write-off of in-process technology which is not tax deductible. 
Excluding  the non-recurring write-off of in-process technology, the Company's
effective  tax  rate  for  the first six months of fiscal 1996 was 36.5%.  The
reduced  tax rate in fiscal 1997 resulted from legislation reinstating the R&D
Tax  Credit  as  well as an increase in foreign operations where tax rates are
lower  than  the  U.  S.  effective  tax  rate.


RISK  FACTORS

The  following  risk  factors  may  be associated with the Company's business:

Factors  Affecting  Future  Operating  Results

The  semiconductor  industry  is  characterized by rapid technological change,
intense  competitive  pressure  and  cyclical  market patterns.  The Company's
results  of  operations  are  affected by a wide variety of factors, including
general  economic  conditions  and  conditions  specific  to the semiconductor
industry,  decreases  in average selling price over the life of any particular
product,  the  timing and implementation of new product introductions (both by
the  Company  and  its  competitors),  the  timely  implementation  of  new
manufacturing  technologies, the ability to safeguard patents and intellectual
property in a rapidly evolving market, and rapid escalation of demand for some
products  in  the  face of equally steep decline in demand for others.  Market
demand  for  the  Company's  products,  particularly  for  those most recently
introduced,  can  be  difficult  to predict, especially in light of customers'
demands  to  shorten  product  lead  time and minimize inventory levels.  This
could  lead  to  revenue  volatility  if  the  Company  were unable to provide
sufficient  quantities of specified products in a given quarter.  In addition,
any  difficulty  in  achieving  targeted  yields  could  adversely  impact the
Company's  results  of  operations.    The  Company attempts to identify these
changes  in  market  conditions  as soon as possible; however, the rapidity of
their onset makes prediction of and reaction to such events difficult.  Due to
the foregoing and other factors, past results, such as those described in this
report,  are  a  much  less useful predictor of the future than is the case in
many  older,  more  stable  and  less  dynamic  industries.

The  semiconductor  industry  has  historically  been  cyclical and subject to
significant  economic  downturns at various times, characterized by diminished
product  demand,  accelerated  erosion  of  average  selling  prices  and
overcapacity.    The  Company  may  experience  substantial  period-to-period
fluctuations in future operating results due to general semiconductor industry
conditions,  overall  economic  conditions  or  other  factors.

Currently,  most  of the Company's operations are centered in an area that has
been seismically active.  Should there be a major earthquake in this area, the
Company's  operations  may  be  disrupted  resulting  in  the inability of the
Company  to  ship  products  in  a timely manner, thereby materially adversely
affecting  the  Company's  business.

In  addition,  the  securities  of  many  high  technology  companies  have
historically  been  subject to extreme price and volume fluctuations, a factor
which  may  adversely  affect  the market price of the Company's Common Stock.

Dependence  Upon  Independent  Manufacturers

The  Company  does not manufacture the wafers used for its products.  To date,
most of the Company's wafers have been manufactured by Seiko Epson Corporation
(Seiko),  Yamaha  Corporation  (Yamaha)  and  United  Microelectronics  
<PAGE>
Corporation  (UMC).   The Company has depended upon these suppliers and others
to  produce  wafers  with  competitive  performance and cost attributes and to
deliver  them  to the Company in a timely manner.  While the timeliness, yield
and  quality  of  wafer  deliveries  to  date  from  these suppliers have been
acceptable,  there  can  be  no assurance that manufacturing problems will not
occur  in  the  future.    Any  prolonged  inability  to  obtain  wafers  with
competitive  performance  and  cost  attributes,  adequate  yields  or  timely
deliveries  from  these  manufacturers,  or  any other circumstance that would
require  the  Company  to  seek  alternative  sources  of  supply, could delay
shipments.  Any significant delays could have a material adverse effect on the
Company's  operating results.  In addition, the Company's purchases from Seiko
and  Yamaha  are  denominated  in  yen, and prolonged periods of a weakened US
dollar  exchange  rate  against  the  yen could adversely affect manufacturing
costs.

The  Company's  long-term  growth  will  depend in large part on the Company's
ability  to  obtain  increased  wafer  fabrication capacity from suppliers.  A
significant  increase in general industry demand or any interruption of supply
could  reduce the Company's supply of wafers or increase the Company's cost of
such  wafers,  thereby  materially adversely affecting the Company's business.

In  order  to  secure additional wafer capacity, the Company from time to time
considers  a  number  of  alternatives,  including, without limitation, equity
investments  in,  or  loans,  deposits,  or  other  financial  commitments to,
independent  wafer  manufacturers  in exchange for production capacity, or the
use  of contracts which commit the Company to purchase specified quantities of
wafers  over  extended periods.  The Company has at times been unable, and may
in  the  future  be  unable,  to  fully  satisfy  customer  demand  because of
production  constraints, including the ability of suppliers and subcontractors
to  provide  materials and services in a timely manner, as well as the ability
of  the Company to process products for shipment.  The Company's future growth
will  depend in part on its ability to locate and qualify additional suppliers
and  subcontractors  and  to  increase  its own capacity to ship products, and
there  can  be  no  assurance  that  the  Company  will be able to do so.  Any
increase  in  these  constraints  on the Company's production could materially
adversely  affect  the  Company's  business.   In this regard, the Company has
entered  into a joint venture, United Silicon Inc., with UMC and other parties
to obtain wafer capacity from a new wafer fabrication facility. However, there
are  many  risks associated with the construction of a new facility, and there
can  be  no  assurance  that such facility will become operational in a timely
manner.    In  addition, the Company's recent agreement with Seiko was made to
obtain  additional  capacity  from a facility currently under construction and
expected  to  provide  wafers  in  volume  in  calendar  1998.  If the Company
requires  additional capacity and such capacity is unavailable, or unavailable
on  reasonable  terms,  the  Company's  business could be materially adversely
affected.

Dependence  on  New  Products

The  Company's  future success depends on its ability to develop and introduce
on a timely basis new products which compete effectively on the basis of price
and  performance  and which address customer requirements.  The success of new
product  introductions  is  dependent  upon  several factors, including timely
completion of new product designs, achievement of acceptable yields and market
acceptance.   No assurance can be given that the Company's product development
efforts  will  be  successful  or  that  its  new products will achieve market
acceptance.  In addition, the average selling price for any particular product
tends  to decrease rapidly over the product's life.  To offset such decreases,
the Company relies primarily on obtaining yield improvements and corresponding
cost reductions in the manufacture of existing products and on introducing new
products  which  incorporate  advanced  features  and  other price/performance
factors  such  that  higher  average  selling  prices  and  higher margins are
achievable  relative  to  mature  product lines.  To the extent that such cost
reductions and new product introductions with higher margins do not occur in a
timely  manner or the Company's products do not achieve market acceptance, the
Company's  operating  results  could  be  adversely  affected.

Competition

The  Company's  FPGA  and  CPLD  products  compete  in  the programmable logic
marketplace,  with  a  substantial  
<PAGE>
majority  of  the  Company's revenues derived from its FPGA product families. 
The industries in which the Company competes are intensely competitive and are
characterized  by  rapid  technological change, rapid product obsolescence and
price  erosion.   The Company expects significantly increased competition both
from  existing  competitors  and from a number of companies that may enter its
market.    Xilinx  believes  that  important  competitive  factors  in  the
programmable  logic market include price, product performance and reliability,
adaptability  of  products  to  specific  applications,  ease  of  use  and
functionality  of  development  system  software,  and  technical  service and
support.    The  Company's  strategy  for  expansion in the programmable logic
market  includes  continued  price reductions commensurate with the ability to
lower  the  cost  of  manufacture  and  continued  introduction of new product
architectures which target high volume, low cost applications.  However, there
can  be  no  assurance  that  the Company will be successful in achieving this
strategy.

The  Company's  major  sources of competition are comprised of three elements:
the  manufacturers  of  custom  CMOS  gate  arrays,  providers of high density
programmable logic products characterized by FPGA-type architectures and other
providers  of  programmable  logic products.  The Company competes with custom
gate  array  manufacturers  on  the  basis  of  lower  design  costs,  shorter
development  schedules and reduced inventory risks.  The primary attributes of
custom  gate  arrays  are high density, high speed and low production costs in
high  volumes.    However, the Company believes that the design specifications
for  many  customers  can  be  met  by  the  density and speed capabilities of
Xilinx's  programmable  logic  products  which are cost effective over a broad
range  of production volumes.  In addition, the Company's efforts to introduce
lower cost architectures are intended to narrow the gap between current custom
gate  array  production costs (in high volumes) and FPGA production costs.  To
the  extent that such efforts are not successful, the Company's business could
be  materially  adversely  affected.

The  Company  competes  with  providers  of  high  density  programmable logic
products  characterized  by  FPGA-type  architectures on the basis of software
capability,  product  functionality, price, performance and customer service. 
The  Company  believes  that  certain  of its patents have been infringed by a
competitor and has initiated legal action to protect its intellectual property
(See  Litigation).

The  benefits  of  programmable  logic have attracted a number of companies to
this  market,  competing  primarily  on  the basis of speed, density or cost. 
Xilinx  recognizes  that different applications require different programmable
technologies,  and the Company is developing multiple architectures, processes
and products to meet these varying customer needs.  Recognizing the increasing
importance of standard software solutions, Xilinx is working to develop common
design  software that supports the full range of integrated circuit products. 
Xilinx  believes  that  automation  and  ease  of  design  will be significant
competitive  factors  in  the  programmable  logic  market.

Although  certain manufacturers of programmable logic devices ("PLDs") compete
with  Xilinx,  significant differences in logic density between most CPLDs and
FPGAs  limit  the  amount  of  competitive overlap.  While the architecture of
CPLDs  gives  them  a  performance advantage in certain instances, the Company
believes  that  the  higher  density  available  with  FPGAs  makes  them more
economical  for  many  designs.

Several  companies, both large and small, have introduced products competitive
with  those  of  the  Company  or have announced their intention to enter this
market.    Some of the Company's competitors may possess innovative technology
which  could  prove  superior to Xilinx's technology in some applications.  In
addition,  the  Company  anticipates  potential  competition from suppliers of
logic  products  based  on new technologies.  Many of the Company's current or
potential  competitors  have  substantially  greater financial, manufacturing,
marketing  and  technical  resources than Xilinx.  This additional competition
could  adversely  affect  the  Company.

Xilinx  also  faces  competition from its licensees.  Under a license from the
Company,  Lucent  Technologies  is  manufacturing  and marketing the Company's
non-proprietary  XC3000  products  and is employing that technology to provide
additional  FPGA  products  offering  higher  density.    Seiko  has rights to
manufacture  the Company's products and market them in Japan and Europe but is
not  currently doing so.  Advanced Micro Devices is licensed to use certain of
the Company's patents to manufacture and market products other than SRAM-based
FPGAs  and,  after March 19, 1997, could also compete directly in this market.


<PAGE>
Intellectual Property

The  Company  relies upon patent, trademark, trade secret and copyright law to
protect  its  intellectual  property.    There  can  be no assurance that such
intellectual  property  rights  can  be successfully asserted in the future or
will not be invalidated, circumvented or challenged.  From time to time, third
parties,  including  competitors  of the Company, may assert exclusive patent,
copyright  and  other  intellectual  property  rights to technologies that are
important  to  the Company.  There can be no assurance that third parties will
not  assert  infringement  claims  against  the  Company  in  the future, that
assertions  by  third parties will not result in costly litigation or that the
Company  would  prevail in such litigation or be able to license any valid and
infringed  patents  from  third  parties  on  commercially  reasonable terms. 
Litigation,  regardless  of  its outcome, could result in substantial cost and
diversion  of  resources  of  the  Company.    Any infringement claim or other
litigation  against  or  by  the Company could materially adversely affect the
Company's  financial  condition  and  results  of  operations.

Litigation

The  Company is currently engaged in patent litigation with Altera Corporation
(Altera).    See  "Legal  Proceedings"  in  Part  II.


FINANCIAL  CONDITION,  LIQUIDITY  AND  CAPITAL  RESOURCES

The  Company's  financial  condition  at  September 28, 1996 remained strong. 
Total  current  assets  exceeded  total  current  liabilities by 4.9 times, as
compared to 5.2 times at March 30, 1996.  Since its inception, the Company has
used  a  combination  of  equity  and debt financing and internal cash flow to
support operations, obtain additional wafer supply capacity, make acquisitions
and  investments  in  complementary  technologies,  obtain  additional capital
equipment  and  facilities  and  finance  inventory  and  accounts receivable.

The Company has generated positive cash flow from operations for the first six
months  of  fiscal 1997.  As of September 28, 1996, the Company had cash, cash
equivalents  and  short-term investments of $423.5 million and working capital
of  $470.7  million  as  compared  to  $378.0  million  and  $436.1  million,
respectively,  at  March  30,  1996.    Cash  generated by operations of $80.4
million  for the first six months of fiscal 1997 was $15.7 million higher than
the  $64.7  million  generated  for  the first six months of fiscal 1996.  The
increase in cash generated by operations during the first six months of fiscal
1997  over  the  comparable  fiscal  1996  period  resulted primarily from the
favorable  impact  of  changes  in  accounts  receivable and accounts payable,
accrued  liabilities and income taxes payable offset by the unfavorable impact
of  inventory  and  deferred  income  on  shipments  to  distributors.

Cash  flows  used  for investing activities for the six months ended September
28,  1996,  included the $30 million advance to Seiko for wafer purchases (see
Note 3 of Notes to Consolidated Condensed Financial Statements), $43.1 million
of  net  short-term  investment purchases and $17.2 million of property, plant
and equipment acquisitions.  Property, plant and equipment additions decreased
$7.9  million  from  the  comparable  fiscal  1996  period.   This decrease is
primarily  due to significantly reduced expenditures relating to the Company's
Ireland  manufacturing  facility  which  were partially offset by expenditures
incurred  relating  to  the  Company's  facility being constructed in Boulder,
Colorado.    In  the  first six months of fiscal 1996, the Company's investing
activities  included $33.4 million (net of cash acquired) incurred relating to
the  acquisition  of  NeoCAD  and $23.8 million of net purchases of restricted
investments  relating  to  the  Company's Corporate facilities offset by $22.3
million  of  net  short-term  investment  proceeds  which  matured.

Cash  flows  provided  by financing activities were $13.1 million in the first
six  months  of  fiscal 1997 and was attributable to $13.6 million in proceeds
from  the  issuance  of  common  stock  under  employee  stock plans offset by
principal  payments  on  capital  lease  obligations of $0.5 million.  For the
comparable  fiscal  1996  period,  $6.9  million  in proceeds from issuance of
common  stock  under  corporate  stock  plans  was  offset  by $0.8 million in
principal  payments  on  capital  lease  obligations.


<PAGE>
Stockholders'  equity  increased  by $70.9 million, principally as a result of
the  net income for the six months ended September 28, 1996, proceeds from the
issuance  of  common stock under employee stock plans and related tax benefits
from  stock  options.

The  Company  has  available  credit  line facilities for up to $47 million of
which  $7  million is intended to meet occasional working capital requirements
for  the  Company's  wholly owned Irish subsidiary.  At September 28, 1996, no
borrowings  were  outstanding  under  the  lines  of  credit.

Under the terms of the Company's agreement relating to the United Silicon Inc.
(USI)  joint  venture,  the  Company  expected to invest additional amounts of
approximately  $68  million  and  $34  million in December 1996 and June 1997,
respectively.  The USI joint venture is accounted for by the equity method, as
the  Company  records 25% of USI's net income as joint venture equity income. 
The Board of Directors of USI recently voted to postpone the wafer fabrication
facility  construction schedule by approximately six months.  As a result, the
additional payments are tentatively postponed to June 1997 and December 1997. 
The  revised  timing  of construction of the facility and the related payments
are  subject  to further change based on overall industry conditions and other
factors.    United  Microelectronics  Corporation  has committed to supply the
Company  with  wafers  manufactured  in an existing facility until capacity is
available  in  the  new  facility.

In  the  first  quarter  of fiscal 1997, the Company entered into an agreement
with Seiko.  The agreement provides for a total payments of $300 million to be
made  to  Seiko,  of which $200 million is in the form of advance payments and
$100  million  is  in  the  form  of  an  advance  or  an alternate form to be
negotiated  at a later date.  Repayment of the advances will be in the form of
wafer  deliveries,  which  are expected to begin in the first half of calendar
1998,  using  dollar  denominated pricing.  The advance payment provision also
provides  for  interest to be paid to the Company in the form of free wafers. 
See  Note  4  of  Notes  to  Consolidated  Condensed  Financial  Statements.

The  Company anticipates that existing sources of liquidity and cash flow from
operations  will  be  sufficient  to  satisfy the Company's cash needs for the
foreseeable  future.   The Company will continue to evaluate opportunities for
investments  to  obtain  additional  wafer  supply  capacity,  procurement  of
additional  capital equipment and facilities, development of new products, and
potential  acquisitions  of  businesses,  products  or technologies that would
complement  the  Company's  businesses  and  may  use  available cash or other
sources  of  funding  for  such  purposes.


Part  II.    Other  Information

Item  1.     Legal  Proceedings.

On June 7, 1993, the Company filed suit against Altera Corporation (Altera) in
the  United  States District Court for the Northern District of California for
infringement  of certain of the Company's patents.  Subsequently, Altera filed
suit  against  the  Company,  alleging  that certain of the Company's products
infringe  certain  Altera  patents.  Fact discovery has been completed in both
cases.    No  trial date has been set.  Both cases have been assigned to Judge
Spencer  Williams.    The  parties had been ordered to mediation but have been
unable to come to a mutually acceptable settlement.  On April 20, 1995, Altera
filed  an  additional  suit  against  the Company in Federal District Court in
Delaware  (the  Delaware  suit),  alleging  that  the  Company's XC5000 family
infringes  a  certain  Altera patent.  The Company answered the Delaware suit,
denying that the XC5000 family infringes the patent in suit, asserting certain
affirmative  defenses  and  counterclaiming  that  the  Altera Max 9000 family
infringes  certain  of  the Company's patents.  The Delaware suit has now been
transferred  to  the United States District Court for the Northern District of
California.    Management  believes  that  it has meritorious defenses to such
claims  and  is defending them vigorously.  The foregoing is a forward looking
statement.    Due  to  the  uncertain nature of the litigation with Altera and
because  the  lawsuits  are still in the pre-trial stage, actual results could
differ  materially.


<PAGE>
There are no other pending legal proceedings of a material nature to which the
Company  is  a  party  or  of  which  any of its property is the subject.  The
Company  knows  of  no  legal  proceedings  contemplated  by  any governmental
authority  or  agency.


Item  4.     Submission  of  Matters  to  a  Vote  of  Security  Holders

The  following  matters  were  submitted  to  a  vote  of  security holders in
conjunction with the Annual Meeting of Stockholders of Xilinx held on July 30,
1996.

(a)  Election of directors
                               Votes For   Votes Withheld
                               ----------  --------------

     Bernard V. Vonderschmitt  62,471,934         772,285
     Willem P. Roelandts       62,839,510         404,709
     Philip T. Gianos          62,850,725         393,494
     John L. Doyle             62,832,866         411,353


(b)      To ratify and approve an amendment to the Company's 1988 Stock Option
Plan  to  increase  the  number  of shares reserved for issuance thereunder by
3,300,000.

      FOR                 AGAINST                 ABSTAIN              NO VOTE
31,643,688               20,911,840               662,164           10,026,527


(c)      To  ratify  and  approve  an amendment to the Company's 1990 Employee
Qualified  Stock  Purchase  Plan to increase the number of shares reserved for
issuance  thereunder  by  460,000  shares.

      FOR                 AGAINST                 ABSTAIN              NO VOTE
49,320,168                3,249,673               647,851           10,026,527


(d)     To ratify the appointment of Ernst & Young LLP as independent auditors
of  the  Company  for  the  year  ended  March  29,  1997.

      FOR                 AGAINST                 ABSTAIN              NO VOTE
63,089,035                52,037                   103,147                  --


Item  6.                  Exhibits  and  Reports  on  Form  8-K.

(a)         Exhibit 11:       Statement of Computation of Net Income Per Share
            Exhibit 12:       Statement of Computation of Ratio of Earning to
                              Fixed  Charges

(b)Reports  on  Form  8-K  -  None

<PAGE>


                                  SIGNATURES





Pursuant  to  the  requirements  of  the  Securities Exchange Act of 1934, the
Registrant  has  duly  caused  this  report  to be signed on its behalf by the
undersigned  thereunto  duly  authorized.




                                    XILINX,  INC.





Date:  November 11, 1996             /s/  Gordon  M.  Steel
                                     -----------------------------------------
                                     Gordon  M.  Steel
                                     Senior  Vice  President  of  Finance  and
                                     Chief  Financial  Officer
                                     (as  principal  accounting  and financial
                                     officer  and  on  behalf  of  Registrant)




                                                                    EXHIBIT 11



<TABLE>
<CAPTION>

                                 XILINX, INC.
               STATEMENT OF COMPUTATION OF NET INCOME PER SHARE
                   (in thousands, except per share amounts)




                                              Three Months Ended       Six Months Ended
                                          -------------  ----------  -----------  ----------
                                            Sept. 28,    Sept. 30,    Sept. 28,   Sept. 30,
                                          -------------  ----------  -----------  ----------
                                              1996          1995        1996         1995
                                          -------------  ----------  -----------  ----------
<S>                                       <C>            <C>         <C>          <C>
PRIMARY
Weighted average number of
     common shares outstanding                   72,853      70,922       72,515      70,710
Incremental common shares
     attributable to outstanding options          6,525       8,679        6,646       7,835
                                          -------------  ----------  -----------  ----------
Total shares                                     79,378      79,601       79,161      78,545
                                          =============  ==========  ===========  ==========
Net income                                $      21,218  $   29,826  $    53,710  $   35,374
                                          =============  ==========  ===========  ==========
Net income per share                      $        0.27  $     0.37  $      0.68  $     0.45
                                          =============  ==========  ===========  ==========

FULLY DILUTED
Weighted average number of
     common shares outstanding                   72,853      70,922       72,515      70,710
Incremental common shares
     attributable to outstanding options          6,874       9,214        6,821       8,402
                                          -------------  ----------  -----------  ----------
Total shares                                     79,727      80,136       79,336      79,112
                                          =============  ==========  ===========  ==========
Net income                                $      21,218  $   29,826  $    53,710  $   35,374
                                          =============  ==========  ===========  ==========
Net income per share                      $        0.27  $     0.37  $      0.68  $     0.45
                                          =============  ==========  ===========  ==========
<FN>


NOTE:    The convertible debt is not included in the calculation of fully diluted net income
per  share  since  their  inclusion  would  have  had  an  anti-dilutive  effect.

</TABLE>

<PAGE>

                                                                EXHIBIT 12


<TABLE>
<CAPTION>


                                 XILINX, INC.
       STATEMENT OF COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES
                        (in thousands, except ratios)


                                               Three Months Ended        Six Months Ended
                                           -------------  ----------  -----------  ----------
                                             Sept. 28,    Sept. 30,    Sept. 28,   Sept. 30,
                                           -------------  ----------  -----------  ----------
                                               1996          1995        1996         1995
                                           -------------  ----------  -----------  ----------
<S>                                        <C>            <C>         <C>          <C>
Income before taxes                        $      31,434  $   46,970  $    81,809  $   66,839
Add fixed charges                                  3,616         229        7,254         525
                                           -------------  ----------  -----------  ----------
    Earnings (as defined)                  $      35,050  $   47,199  $    89,063  $   67,364
                                           =============  ==========  ===========  ==========

Fixed charges
    Interest expense                       $       3,219  $       58  $     6,471  $      163
    Amortization of debt issuance costs              218          --          441          --
    Estimated interest component of rent             179         171          342         362
      expenses
Total fixed charges                        $       3,616  $      229  $     7,254  $      525
                                           =============  ==========  ===========  ==========
Ratio of earnings to fixed charges                   9.7       206.1         12.3       128.3
                                           =============  ==========  ===========  ==========
</TABLE>

<TABLE> <S> <C>


<ARTICLE> 5
<MULTIPLIER> 1000
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          MAR-29-1997             MAR-29-1997
<PERIOD-END>                               SEP-28-1996             SEP-28-1996
<CASH>                                         114,081                 114,081
<SECURITIES>                                   309,403                 309,403
<RECEIVABLES>                                   67,375                  67,375
<ALLOWANCES>                                     3,942                   3,942
<INVENTORY>                                     63,407                  63,407
<CURRENT-ASSETS>                               591,215                 591,215
<PP&E>                                         145,418                 145,418
<DEPRECIATION>                                  55,894                  55,894
<TOTAL-ASSETS>                                 809,713                 809,713
<CURRENT-LIABILITIES>                          120,546                 120,546
<BONDS>                                        250,000                 250,000
                                0                       0
                                          0                       0
<COMMON>                                           730                     730
<OTHER-SE>                                     438,437                 438,437
<TOTAL-LIABILITY-AND-EQUITY>                   809,713                 809,713
<SALES>                                        130,579                 280,779
<TOTAL-REVENUES>                               130,579                 280,779
<CGS>                                           50,658                 103,983
<TOTAL-COSTS>                                  101,115                 201,825
<OTHER-EXPENSES>                               (5,407)                 (9,767)
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                               3,437                   6,912
<INCOME-PRETAX>                                 31,434                  81,809
<INCOME-TAX>                                    10,216                  28,099
<INCOME-CONTINUING>                             21,218                  53,710
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                    21,218                  53,710
<EPS-PRIMARY>                                     0.27                    0.68
<EPS-DILUTED>                                     0.27                    0.68
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission